tRF-22 negatively regulates MXD1 expression by binding to the 3’UTR of MXD1 mRNA, thereby diminishing MXD1’s transcriptional repression of the HIF1A gene and promoting glioma VM formation. Here, MXD1 is linked to central nervous system cancer.